Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Volume 64, Number 1, January 11, 2005
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perry, E.
Right arrow Articles by Ballard, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perry, E.
Right arrow Articles by Ballard, C.
Related Collections
Right arrow Alzheimer's disease
Right arrow Vascular dementia
NEUROLOGY 2005;64:132-133
© 2005 American Academy of Neurology


Brief Communications

Absence of cholinergic deficits in "pure" vascular dementia

E. Perry, PhD, I. Ziabreva, PhD, R. Perry, FRC Path, D. Aarsland, MD and C. Ballard, MRC Psych

From Newcastle General Hospital (Drs. E. Perry, Ziabreva, and R. Perry) and Wolfson Centre for Age Related Diseases (Dr. Ballard), Kings College London, UK; and Central Hospital (Dr. Aarsland), Rogaland, Norway.

Address correspondence and reprint requests to Dr. E.K. Perry, Newcastle General Hospital, MRC Bldg., Westgate Rd., Newcastle upon Tyne, NE4 6BE, UK; e-mail: e.k.perry{at}ncl.ac.uk

Choline acetyltransferase in temporal cortex was evaluated as a marker of cholinergic function in autopsied dementia cases (9 vascular dementia [VaD] cases, 12 "mixed" VaD and Alzheimer disease [AD] cases, 10 AD cases, 12 control subjects). Patients with AD (t = 2.5, p = 0.02) and "mixed" VaD and AD (t = 3.8, p = 0.001) had greater cholinergic deficits than age-matched control subjects and patients with "pure" VaD. The absence of cholinergic deficits in "pure" VaD may be relevant to the pharmacologic treatment of these patients.


Received April 6, 2004. Accepted in final form August 17, 2004.




This article has been cited by other articles:


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
P. J. Modrego, C. Rios, J. M. Perez Trullen, J. M. Errea, M. J. Garcia-Gomara, and S. Sanchez
The Cerebrovascular Pathology in Alzheimer's Disease and Its Influence on Clinical Variables
American Journal of Alzheimer's Disease and Other Dementias, March 1, 2008; 23(1): 91 - 96.
[Abstract] [PDF]


Home page
StrokeHome page
J. S. Keverne, W. C. R. Low, I. Ziabreva, J. A. Court, A. E. Oakley, and R. N. Kalaria
Cholinergic Neuronal Deficits in CADASIL
Stroke, January 1, 2007; 38(1): 188 - 191.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Chui and I. Skoog
Advances in Vascular Cognitive Impairment 2005
Stroke, February 1, 2006; 37(2): 323 - 325.
[Full Text] [PDF]


Home page
NeurologyHome page
H. Tomimoto, R. Ohtani, M. Ihara, and E.K. Perry
Absence of cholinergic deficits in "pure" vascular dementia
Neurology, July 12, 2005; 65(1): 179 - 179.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

Absence of cholinergic deficits in "pure" vascular dementia
Hidekazu Tomimoto, et al.
Neurology Online, 1 Mar 2005 [Full text]
Reply to Tomimoto
E.K. Perry
Neurology Online, 1 Mar 2005 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.